VTVenus Tang

Venus Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Venus Tang has a total of 123 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A systematic review on mental health issues in adults with newly diagnosed epilepsy

    by Venus Tang, Prisca R. Bauer, Janelle Wagner, Nuran Aydemir, Natela Okujava, Siew‐Tim Lai, Action Amos, Cory Hooper, Gus A. Baker

    Objective: Mental health conditions often co‐occur with epilepsy, causing burden and stress beyond seizures. Some of these conditions can emerge early and even predate the onset of seizure and/or epilepsy diagnosis. This systematic review synthesizes evidence on mental health outcomes in adults with newly diagnosed epilepsy (NDE). Methods: A systematic literature search was conducted up to September 2025. All quantitative studies were included without restriction to study types. Mental health outcomes included a board range of mood, anxiety, quality of life, and stigma as primary or secondary outcome measures that were assessed and reported using validated scales. Standard methodological procedures for literature search, data collection, assessment of risk of bias, and analysis were used based on the Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) 2020 guideline. Results: Twenty‐one publications ( n = 4728 adults) across 10 countries were included, of which 12 (57%) showed low risk of bias. Methodological heterogeneity precluded meta‐analysis. Depressive and anxiety symptoms were the most frequently assessed, with 11%–50% (data from 14 papers) and 25%–35% (11 papers) of NDE screened positive on validated screening tools, respectively. Structured diagnostic tools in two papers revealed clinical depression in 2.9%–13.3% and anxiety/neurotic disorders in approximately one‐quarter of NDE. The prevalence of perceived stigma was reported in 25%–53% of NDE; quality of life was impaired by mood symptom, stigma, and role disability. Significance: Mental health conditions impose a substantial early burden among adults with NDE. Managing this burden requires integrating routine screening into early care pathways as a first step, coupled with a tiered psychiatric diagnostic process. Psychoeducation on these mental health risks should also be integrated into epilepsy care to promote awareness and access to services.

  • Feasibility of psychological screening in a tertiary epilepsy clinic

    by Kheng-Seang Lim, Kian-Yong Wong, Yong-Chuan Chee, Si-Lei Fong, Xuen Yu, Chong-Guan Ng, Venus Tang, Siew-Tim Lai, Christine Audrey, Aminath Shauna, et al.


  • Caregiver burden for adults with epilepsy in Malaysian families: A qualitative study

    by Xuen Yu, Kheng-Seang Lim, Li-Yoong Tang, Venus Tang, Ying-Huan Lim, Si-Lei Fong, Chong-Tin Tan


  • Deep brain stimulation of the anterior nucleus of the thalamus for drug‐resistant epilepsy: Long‐term efficacy and outcomes from a prospective cohort

    by Eric Y. H. Cheung, Claire K. Y. Lau, Howan H. W. Leung, Eva L. W. Fung, Venus Y. H. Tang, Tom C. Y. Cheung, William K. M. Kwong, Xian Lun Zhu, David Y. C. Chan, Danny T. M. Chan, et al.

    Aim: The anterior nucleus of the thalamus (ANT) has been one of the deep brain stimulation (DBS) targets for drug‐resistant epilepsy. This study aims to investigate the control of seizures among patients with ANT DBS for epilepsy. We have pioneered DBS for epilepsy in Hong Kong since 2015 and this study aims to report the long‐term outcomes from a prospective cohort.Methods: This is a prospective cohort study of ANT DBS for adult patients with drug‐resistant epilepsy, who are unsuitable for resective epilepsy surgery.Results: Six patients (3 females and 3 males, mean age 31.3) received bilateral ANT DBS in a tertiary university hospital from 2015 to 2018 (one in 2015, two in 2017 and three in 2018). Both frontal transventricular and parietal approaches were used. The active contacts were selected based on the closest Euclidean distance to the mammillothalamic tract and ANT junction. Five of the six cases (83.3%) achieved greater than 50% reduction in seizures after the operations. The median percentage of reduction in seizures was 58.5% at 3 years after DBS (range, 32.7%–80%). Overall, there was a trend of improving seizure control rate from year 1 to year 6 after the ANT DBS operations.Conclusions: This is the first report of ANT DBS for drug‐resistant epilepsy in Hong Kong. The results are encouraging. ANT DBS for drug‐resistant epilepsy is effective and sustained in long term. The treatment option of ANT DBS should be considered in suitable candidates with drug‐resistant epilepsy in our locality.


  • Pre-operative cognitive burden as predictor of motor outcome following bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease

    by Venus Tang, Xian Lun Zhu, Claire Lau, Anne Chan, Karen Ma, Jonas Yeung, Tom Cheung, Jill Abrigo, David Yuen Chung Chan, Danny Chan, et al.

    Introduction The interrelationship between neurocognitive impairments and motor functions was observed in patients with advanced Parkinson’s disease (PD). This study was conducted to identify pre-operative neurocognitive and clinical predictors of short-term motor outcome following subthalamic nucleus deep brain stimulation (STN-DBS). Methods All consecutive PD patients who were eligible for bilateral STN-DBS from 2009 to 2019 were evaluated before and at 1 year following surgery. Standard motor evaluation and neurocognitive tests including global cognition, memory, executive functions (attention and category fluency), confrontational speech, visuospatial abilities, and mood were conducted at baseline. The post-operative STN-DBS effects were assessed at 1 year following the surgery. Multiple regression analysis was applied to identify baseline independent predictors of post-operative STN-DBS effect. Results A total of 82 patients were analyzed. It was found that younger age at operation, higher levodopa responsiveness at baseline based on UPDRS-III total score, and better baseline verbal delayed memory and category fluency predicted post-operative motor outcome at 1 year following STN-DBS (F = 9.639, p < 0.001, R2 = .340). Conclusion Our findings demonstrated the role of baseline cognitive burden, especially cognitive processes related to frontostriatal circuits, was significant clinical predictors of short-term motor outcomes following STN-DBS. Profile analysis of neurocognitive functions at baseline is recommended.


  • A retrospective comparison of cognitive performance in individuals with advanced Parkinson’s Disease in Hong Kong and Canada

    by Vivian Kwan, David Shum, Angela Haffenden, Keith Owen Yeates, Alice Kwok, Herman Lau, Wai Sang Poon, Danny Chan, X. L. Zhu, David Chan, et al.

    A deeper understanding of the cross-cultural applicability of cognitive tests across countries and cultures is needed to better equip neuropsychologists for the assessment of patients from diverse backgrounds. Our study compared cognitive test scores in patients with advanced Parkinson’s disease (PD) at the Prince of Wales Hospital (n = 63; Hong Kong) and the Foothills Medical Center (n = 20; Calgary, Canada). The groups did not differ in age or sex (p > .05), but Western patients had significantly more years of education (M = 14.2, SD = 2.7) than Asian patients (M = 10.33, SD = 4.4). Cognitive tests administered to both groups included: digit span, verbal fluency (animals), the Boston Naming Test, and verbal memory (California Verbal Learning Test or Chinese Auditory Verbal Learning Test). Testing was completed before and 12 months after deep brain stimulation surgery. Results showed cognitive performance was similar across time, but significant group differences were found on digit span forward (longer among patients from Hong Kong; F(1, 75) = 44.155, p < .001) and the Boston Naming Test (higher percent spontaneous correct among patients from Canada; F(1, 62) = 7.218, p = .009, η2 = 0.104), after controlling for age, sex, and years of education. In conclusion, our findings provide preliminary support for the similarity of Chinese versions of tests originally developed for Western populations. Also, we caution that some aspects of testing may be susceptible to cultural bias and therefore warrant attention in clinical practice and refinement in future test development for Asian patients.

  • Psychological treatments for people with epilepsy

    by Rosa Michaelis, Venus Tang, Sarah J Nevitt, Janelle L Wagner, Avani C Modi, William Curt LaFrance Jr, Laura H Goldstein, Milena Gandy, Rebecca Bresnahan, Kette Valente, et al.

    Background Given the significant impact epilepsy may have on the health‐related quality of life (HRQOL) of individuals with epilepsy and their families, there is increasing clinical interest in evidence‐based psychological treatments, aimed at enhancing psychological and seizure‐related outcomes for this group. This is an updated version of the original Cochrane Review published in Issue 10, 2017. Objectives To assess the impact of psychological treatments for people with epilepsy on HRQOL outcomes. Search methods For this update, we searched the following databases on 12 August 2019, without language restrictions: Cochrane Register of Studies (CRS Web), which includes randomized or quasi‐randomized controlled trials from the Specialized Registers of Cochrane Review Groups including Epilepsy, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid, 1946 to 09 August 2019), and PsycINFO (EBSCOhost, 1887 onwards), and from PubMed, Embase, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform (ICTRP). We screened the references from included studies and relevant reviews, and contacted researchers in the field for unpublished studies. Selection criteria We considered randomized controlled trials (RCTs) and quasi‐RCTs for this review. HRQOL was the main outcome. For the operational definition of 'psychological treatments', we included a broad range of skills‐based psychological treatments and education‐only interventions designed to improve HRQOL, seizure frequency and severity, as well as psychiatric and behavioral health comorbidities for adults and children with epilepsy. These psychological treatments were compared to treatment as usual (TAU), an active control group (such as social support group), or antidepressant pharmacotherapy. Data collection and analysis We used standard methodological procedures expected by Cochrane. Main results We included 36 completed RCTs, with a total of 3526 participants. Of these studies, 27 investigated skills‐based psychological interventions. The remaining nine studies were education‐only interventions. Six studies investigated interventions for children and adolescents, three studies investigated interventions for adolescents and adults, and the remaining studies investigated interventions for adults. Based on satisfactory clinical and methodological homogeneity, we pooled data from 11 studies (643 participants) that used the Quality of Life in Epilepsy‐31 (QOLIE‐31) or other QOLIE inventories (such as QOLIE‐89 or QOLIE‐31‐P) convertible to QOLIE‐31. We found significant mean changes for the QOLIE‐31 total score and six subscales (emotional well‐being, energy and fatigue, overall QoL, seizure worry, medication effects, and cognitive functioning). The mean changes in the QOLIE‐31 total score (mean improvement of 5.23 points, 95% CI 3.02 to 7.44; P < 0.001), and the overall QoL score (mean improvement of 5.95 points, 95% CI 3.05 to 8.85; P < 0.001) exceeded the threshold of minimally important change (MIC: total score: 4.73 points; QoL score: 5.22 points), indicating a clinically meaningful postintervention improvement in HRQOL. We downgraded the certainty of the evidence provided by the meta‐analysis due to serious risks of bias in some of the included studies. Consequently, these results provided moderate‐certainty evidence that psychological treatments for adults with epilepsy may enhance overall HRQOL. Authors' conclusions Implications for practice: Skills‐based psychological interventions improve HRQOL in adults and adolescents with epilepsy. Adjunctive use of skills‐based psychological treatments for adults and adolescents with epilepsy may provide additional benefits in HRQOL when these are incorporated into patient‐centered management. We judge the evidence to be of moderate certainty. Implications for research: Investigators should strictly adhere to the CONSORT guidelines to improve the quality of reporting on their interventions. A thorough description of intervention protocols is necessary to ensure reproducibility. When examining the effectiveness of psychological treatments for people with epilepsy, the use of standardized HRQOL inventories, such as the Quality of Life in Epilepsy Inventories (QOLIE‐31, QOLIE‐31‐P, and QOLIE‐89) would increase comparability. Unfortunately, there is a critical gap in pediatric RCTs and RCTs including people with epilepsy and intellectual disabilities. Finally, in order to increase the overall quality of RCT study designs, adequate randomization with allocation concealment and blinded outcome assessment should be pursued. As attrition is often high in research that requires active participation, an intention‐to‐treat analysis should be carried out. Treatment fidelity and treatment competence should also be assessed. These important dimensions, which are related to 'Risk of bias' assessment, should always be reported.


  • Positive psychological interventions for neurological disorders: A systematic review

    by Siew-Tim Lai, Kheng-Seang Lim, Wah-Yun Low, Venus Tang

    Objectives: Psychological well-being in people with neurological diseases can be compromised due to brain damage or psychological reactions towards chronic disabilities. This systematic review evaluated the efficacy of positive psychological intervention (PPI) in neurological populations. Methods: Previous studies relevant to this topic were identified by searches in PUBMED, EMBASE, MEDLINE, and PSYCINFO databases from Jan 1980 to August 2017. Results: Of 1361 articles identified, 31 studies were included. Nineteen studies were randomized controlled trials. Sixteen studies had sample sizes of less than 30. Twelve studies were rated as high quality using the National Heart, Lung, and Blood Institute (NHLBI) quality assessment tools. Six therapies were found: mindfulness-based approaches, positive savoring, life summary, expressive-based, hope-based interventions, and character strengths. These interventions were shown to improve quality of life, reduce symptomatic distress, and depressive symptoms. Conclusion: PPIs promote well-being among patients with neurological deficits. For PPIs to be considered as an evidence-based practice, more trials with adequate statistical power are required.


  • Psychological treatments for adults and children with epilepsy: Evidence‐based recommendations by the International League Against Epilepsy Psychology Task Force

    by Rosa Michaelis, Venus Tang, Laura H. Goldstein, Markus Reuber, William Curt LaFrance, Tobias Lundgren, Avani C. Modi, Janelle L. Wagner

    Summary: Given the significant impact that psychosocial factors and epilepsy treatments can have on the health‐related quality of life (HRQOL) of individuals with epilepsy and their families, there is great clinical interest in the role of psychological evaluation and treatments to improve HRQOL and comorbidities. Therefore, the International League Against Epilepsy (ILAE) charged the Psychology Task Force with the development of recommendations for clinical care based on evaluation of the evidence from their recent Cochrane review of psychological treatments in individuals with epilepsy. The literature search for a recent Cochrane review of randomized controlled trials investigating psychological treatments for individuals with epilepsy constitutes the key source of evidence for this article. To provide practical guidance to service providers, we provide ratings on study research designs based on (1) the American Academy of Neurology's Level of Evidence system and (2) the Grading of Recommendations, Assessment, Development, and Evaluation system. This paper is the culmination of an international collaboration process involving pediatric and adult psychologists, neurologists, psychiatrists, and neuropsychiatrists. The process and conclusions were reviewed and approved by the ILAE Executive Committee. The strongest evidence for psychological interventions was identified for the most common mental health problems, including depression, neurocognitive disturbances, and medication adherence. Psychological interventions targeting the enhancement of HRQOL and adherence and a decrease in comorbidity symptoms (anxiety, depression) should be incorporated into comprehensive epilepsy care. There is a range of psychological strategies (ie, cognitive behavioral therapy and mindfulness‐based therapies) that show promise for improving the lives of persons with epilepsy, and clinical recommendations are provided to assist epilepsy health care providers in treating the comorbidities and challenges associated with epilepsy and its treatments.